Nektar Therapeutics (NASDAQ:NKTR)
| 2.61 Delayed Data As of Jan 27 |  +0.145 / +5.89%Today’s Change | 1.99 Today|||52-Week Range 11.59 | +15.27% Year-to-Date |
Largest transactions by value over
| Name | Type | Date | Shares traded | Share price | Transaction value | Since transaction |
|---|---|---|---|---|---|---|
Zalevsky Jonathan Chief Research & Development Officer |  Sale | 8/18/2022 | 73,716 | $4.65 | $342.8K | -44.23% |
Robin Howard W President & Chief Executive Officer | Sale | 5/16/2022 | 36,529 | $3.95 | $144.3K | -32.73% |
Robin Howard W President & Chief Executive Officer | Sale | 2/16/2022 | 12,480 | $10.95 | $136.7K | -76.68% |
Robin Howard W President & Chief Executive Officer | Sale | 11/16/2022 | 38,014 | $3.57 | $135.7K | -25.85% |
Zalevsky Jonathan Chief Research & Development Officer | Sale | 2/16/2022 | 10,912 | $10.95 | $119.5K | -76.68% |
Zalevsky Jonathan Chief Research & Development Officer | Sale | 5/16/2022 | 21,673 | $3.95 | $85.6K | -32.73% |
Labrucherie Gilbert M Chief Operating & Financial Officer & Senior VP | Sale | 2/16/2022 | 7,579 | $10.95 | $83.0K | -76.68% |
Eastham Karin Director | Sale | 9/13/2022 | 21,267 | $3.61 | $76.8K | -26.48% |
Labrucherie Gilbert M Chief Operating & Financial Officer & Senior VP | Sale | 5/16/2022 | 17,448 | $3.95 | $68.9K | -32.73% |
Robin Howard W President & Chief Executive Officer | Sale | 8/16/2022 | 13,759 | $4.76 | $65.5K | -44.23% |
Page of 4